Renal Cancer
Oncocytoma: A Differential Consideration for an Incidentally Detected FDG-Avid Renal Mass on PET/CT
January 18, 2018
First-line vascular endothelial growth factor-targeted therapy in renal cell carcinoma: priming the tumor microenvironment for immunotherapy
January 18, 2018
Optimizing Treatment Approaches in Advanced Renal Cancer
January 18, 2018
A five-gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma
January 17, 2018
Collection of real-world data on nivolumab's effectiveness in renal cell carcinoma: rationale for an observational study
January 17, 2018
The prospects for combination therapy with capecitabine in the rapidly evolving treatment landscape of renal cell carcinoma
January 17, 2018
The Effect of Patient and Surgical Characteristics on Renal Function After Partial Nephrectomy
January 16, 2018
FDA Grants Breakthrough Designation for Combination Therapy in Advanced and/or Metastatic Renal Cell Carcinoma
January 15, 2018
Three-Dimensional Physical Model-Assisted Planning and Navigation for Laparoscopic Partial Nephrectomy in Patients with Endophytic Renal Tumors
January 15, 2018
Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell Carcinoma
January 15, 2018
Differential prognostic value of MYC immunohistochemistry in subtypes of papillary renal cell carcinoma
January 12, 2018
Examining the bleeding incidences associated with targeted therapies used in metastatic renal cell carcinoma
January 12, 2018
Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
January 12, 2018